LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- Product NDC
- 72189-325
- 11-digit product format
- 721890325
- Labeler code
- 72189
- Product ID
- 72189-325_2c3d3786-4083-1a01-e063-6394a90a6cac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA204901
- Marketing category
- ANDA
- Marketing start
- 2022-02-16
- Substance
- HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- Active strength
- 12.5; 50 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| 3ST302B24A | LOSARTAN POTASSIUM | 124750-99-8 | LOSARTAN POTASSIUM |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72189-325-30 | 72189032530 | 30 TABLET, FILM COATED in 1 BOTTLE (72189-325-30) | 2022-02-16 | No | No | Historical |
| 72189-325-90 | 72189032590 | 90 TABLET, FILM COATED in 1 BOTTLE (72189-325-90) | 2022-02-16 | No | No | Historical |